61
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients

, , , , &
Pages 261-269 | Published online: 05 Jul 2014

References

  • BlockGAKlassenPSLazarusJMOfsthunNLowrieEGChertowGMMineral metabolism, mortality, and morbidity in maintenance hemodialysisJ Am Soc Nephrol20041582208221815284307
  • KestenbaumBSampsonJNRudserKDSerum phosphate levels and mortality risk among people with chronic kidney diseaseJ Am Soc Nephrol200516252052815615819
  • Cannata-AndiaJBRoman-GarciaPHruskaKThe connections between vascular calcification and bone healthNephrol Dial Transplant201126113429343622039012
  • National Kidney FoundationK/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseAm J Kidney Dis2003424 Suppl 3S1S20114520607
  • Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work GroupKDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)Kidney Int Suppl2009113S1S130
  • NooriNSimsJJKoppleJDOrganic and inorganic dietary phosphorus and its management in chronic kidney diseaseIran J Kidney Dis2010428910020404416
  • ColadonatoJAControl of hyperphosphatemia among patients with ESRDJ Am Soc Nephrol200516Suppl 2S107S11416251245
  • IkizlerTADietary protein restriction in CKD: the debate continuesAm J Kidney Dis200953218919119166797
  • RufinoMde BonisEMartínMIs it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?Nephrol Dial Transplant199813Suppl 365679568824
  • ShinabergerCSGreenlandSKoppleJDIs controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?Am J Clin Nutr20088861511151819064510
  • Kalantar-ZadehKSupasyndhOLehnRSMcAllisterCJKoppleJDNormalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20J Ren Nutr2003131152512563619
  • LacsonEIkizlerTALazarusJMTengMHakimRMPotential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costsJ Ren Nutr200717636337117971308
  • PupimLBCaglarKHakimRMShyrYIkizlerTAUremic malnutrition is a predictor of death independent of inflammatory statusKidney Int20046652054206015496179
  • RambodMBrossRZitterkophJAssociation of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort studyAm J Kidney Dis200953229830919070949
  • CollinsAJFoleyRNChaversBUnited States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United StatesAm J Kidney Dis2012591 Suppl 1A7e1e42022177944
  • BeckerGJWalkerRGHewitsonTDPedagogosEPhosphate levels – time for a rethink?Nephrol Dial Transplant20092482321232419443650
  • DaneseMDBelozeroffVSmirnakisKRothmanKJConsistent control of mineral and bone disorder in incident hemodialysis patientsClin J Am Soc Nephrol2008351423142918596117
  • RingTSandenAKHansenHHHalkierPNielsenCFogLUltradian variation in serum phosphate concentration in patients on haemodialysisNephrol Dial Transplant199510159637724030
  • IsakovaTGutiérrezOMChangYPhosphorus binders and survival on hemodialysisJ Am Soc Nephrol200920238839619092121
  • GutiérrezOMMannstadtMIsakovaTFibroblast growth factor 23 and mortality among patients undergoing hemodialysisN Engl J Med2008359658459218687639
  • MelamedMLEustaceJAPlantingaLChanges in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal studyKidney Int200670235135716738536
  • SelvarajahVPaseaLOjhaSWilkinsonIBTomlinsonLAPre-dialysis systolic blood pressure-variability is independently associated with all-cause mortality in incident haemodialysis patientsPLoS One201491e8651424489735
  • PelletierSRothHBouchetJLDruekeTLondonGFouqueDFrench Phosphorus and Calcium Observatory investigatorsMineral and bone disease pattern in elderly haemodialysis patientsNephrol Dial Transplant20102593062307020237058
  • YavuzAErsoyFFPassadakisPSPhosphorus control in peritoneal dialysis patientsKidney Int Suppl2008108S152S15818379539
  • YoungEWAlbertJMSatayathumSPredictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns StudyKidney Int20056731179118715698460
  • KaramanidouCClatworthyJWeinmanJHorneRA systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal diseaseBMC Nephrol20089218237373
  • ArenasMDMalekTGilMTMoledousAAlvarez-UdeFReig-FerrerAChallenge of phosphorus control in hemodialysis patients: a problem of adherence?J Nephrol201023552553420119931
  • LeckerSHGiven the science on malnutrition, how does the clinician respond? Practical lessons for and application to the dialysis patientClin J Am Soc Nephrol20094Suppl 1S64S7019996008
  • PiresAAdragãoTPaisMJVinhasJFerreiraHGInferring disease mechanisms from epidemiological data in chronic kidney disease: calcium and phosphorus metabolismNephron Clin Pract20091123c137c14719390214
  • SlatopolskyEBrownADussoARole of phosphorus in the pathogenesis of secondary hyperparathyroidismAm J Kidney Dis2001371 Suppl 2S54S5711158862
  • UhligKBernsJSKestenbaumBKDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD)Am J Kidney Dis201055577379920363541
  • LopesAATongLThummaJPhosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional statusAm J Kidney Dis20126019010122385781